Acute otitis externa
▶TO THE EAR
▶Child 1–17 years: Apply 0.25 mL twice daily for 7 days,
each 0.25 mL dose contains 0.5 mg ciprofloxacin
▶Adult: Apply 0.25 mL twice daily for 7 days, each
0.25 mL dose contains 0.5 mg ciprofloxacin
PDF page 1283
Known (or at risk of) perforated tympanic
membrane
PDF page 1283
For choice
of antibacterial therapy, see Ear infections, antibacterial
therapy p. 534.
l HANDLING AND STORAGE Manufacturer advises discard
any ampoules remaining 8 days after opening the pouch.
PDF page 1283
Scottish Medicines Consortium (SMC) decisions
SMC No. 1320/18
The Scottish Medicines Consortium has advised (April 2018)
that ciprofloxacin ear drops (Cetraxal ®) are recommended
for use within NHS Scotland for treatment of acute otitis
externa in adults and children over 1 year with an intact
tympanic membrane, caused by ciprofloxacin susceptible
microorganisms when off-label or unlicensed ciprofloxacin
formulations would otherwise be used.
All Wales Medicines Strategy Group (AWMSG) decisions
AWMSG No. 1343
The All Wales Medicines Strategy Group has advised (July
2018) that ciprofloxacin (Cetraxal ®) is recommended as an
option for use within NHS Wales for the treatment of acute
otitis externa in adults and children older than 1 year with
an intact tympanic membrane, caused by ciprofloxacin
susceptible microorganisms.
PDF page 1283